Apogee Technology Schedules Third Quarter 2006 Earnings Conference Call

  
    
  
  
    
      Apogee Technology, Inc. (AMEX:ATA), an emerging nanotechnology and 
      micro-systems company that designs, develops and commercializes medical 
      devices and sensor products, will hold a conference call to discuss its 
      Third Quarter 2006 results and recent developments on Wednesday, 
      November 15th 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time).
    
    
      This call is being webcast by CCBN and can be accessed at Apogee’s 
      web site at www.apogeemems.com.
    
    
      The call can also be accessed via teleconference using the following 
      dial-in and passcode numbers:
    
    
      Dial In # 866-578-5788
    
    
      International Dial In # 617-213-8057
    
    
      Participant Passcode 36449826
    
    
      The webcast is also being distributed over CCBN’s 
      Investor Distribution Network to both institutional and individual 
      investors. Individual investors can listen to the call through CCBN’s 
      individual investor center at www.fulldisclosure.com 
      or by visiting any of the investor sites in CCBN’s 
      Individual Investor Network. Institutional investors can access the call 
      via CCBN’s password-protected event management 
      site, StreetEvents (www.streetevents.com).
    
    
      About Apogee Technology, Inc.
    
    
      Apogee Technology designs, develops and commercializes proprietary 
      medical device and sensor products using its MEMS and nanotechnology for 
      the medical, automotive, industrial and consumer markets. The Company is 
      developing its PyraDerm(TM) solution for enhanced transdermal drug 
      delivery and has introduced a family of pressure sensors. Apogee's goal 
      is to provide value-added and cost-savings solutions for our customers 
      and, in so doing, to become a global leader in the sensors and medical 
      device field. The Company operates a worldwide marketing and sales 
      organization with offices in the US and Japan. For more information 
      please visit our web site at: http://www.apogeemems.com.
    
    
      PyraDerm(TM), and Sensilica(TM) are trademarks of Apogee Technology, 
      Inc. All other product names noted herein may be trademarks of their 
      respective holders. Certain statements made herein that use the words 
      "anticipate," "hope," "estimate," "project," "intend," "plan," "expect," 
      "believe" and similar expressions are intended to identify 
      forward-looking statements within the meaning of the Private Securities 
      Litigation Reform Act of 1995. These forward-looking statements involve 
      known and unknown risks and uncertainties, which could cause the actual 
      results, performance or achievements of the company to be materially 
      different from those that may be expressed or implied. Please refer to 
      the Company's risk factors as set forth in the Company's filings with 
      the Securities and Exchange Commission, including its reports on Forms 
      10-KSB and 10-QSB.
    
  
Apogee Technology, Inc. (AMEX:ATA), an emerging nanotechnology and
micro-systems company that designs, develops and commercializes
medical devices and sensor products, will hold a conference call to
discuss its Third Quarter 2006 results and recent developments on
Wednesday, November 15th 2006, at 4:30 p.m. Eastern Time (3:30 p.m.
Central Time).

   This call is being webcast by CCBN and can be accessed at Apogee's
web site at www.apogeemems.com.

   The call can also be accessed via teleconference using the
following dial-in and passcode numbers:

   Dial In # 866-578-5788

   International Dial In # 617-213-8057

   Participant Passcode 36449826

   The webcast is also being distributed over CCBN's Investor
Distribution Network to both institutional and individual investors.
Individual investors can listen to the call through CCBN's individual
investor center at www.fulldisclosure.com or by visiting any of the
investor sites in CCBN's Individual Investor Network. Institutional
investors can access the call via CCBN's password-protected event
management site, StreetEvents (www.streetevents.com).

   About Apogee Technology, Inc.

   Apogee Technology designs, develops and commercializes proprietary
medical device and sensor products using its MEMS and nanotechnology
for the medical, automotive, industrial and consumer markets. The
Company is developing its PyraDerm(TM) solution for enhanced
transdermal drug delivery and has introduced a family of pressure
sensors. Apogee's goal is to provide value-added and cost-savings
solutions for our customers and, in so doing, to become a global
leader in the sensors and medical device field. The Company operates a
worldwide marketing and sales organization with offices in the US and
Japan. For more information please visit our web site at:
http://www.apogeemems.com.

   PyraDerm(TM), and Sensilica(TM) are trademarks of Apogee
Technology, Inc. All other product names noted herein may be
trademarks of their respective holders. Certain statements made herein
that use the words "anticipate," "hope," "estimate," "project,"
"intend," "plan," "expect," "believe" and similar expressions are
intended to identify forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements involve known and unknown risks and
uncertainties, which could cause the actual results, performance or
achievements of the company to be materially different from those that
may be expressed or implied. Please refer to the Company's risk
factors as set forth in the Company's filings with the Securities and
Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.